New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 30, 2014
16:34 EDTRTRX, LGF, AGN, SHPG, BLOX, SPLK, NPSP, VRXOn The Fly: Closing Wrap
The market began the session in quiet fashion and remained that way throughout the day. There was little for investors to get excited about, as the day’s economic data proved to be a mixed bag. The averages moved in a narrow range on very light volume while the news flow slowed to a trickle. With memorial Day kicking off the summer season and the week shortened by a day, investors appeared content to let the market drift in the last trading day of the week and the month, albeit near record levels. ECONOMIC EVENTS: In the U.S., personal income rose 0.3% in April, matching expectations, while consumer spending fell 0.1%, versus an expected increase of 0.2%. The Chicago ISM index rose 2.5 points to 65.5 in May, which was much better than expected. The final University of Michigan consumer confidence reading for May came in at 81.9, which was up just 0.1 from the prior reading and a hair below the expected 82.5 figure. COMPANY NEWS: Valeant Pharmaceuticals (VRX) raised its offer for Allergan (AGN) for the second time this week. Under the newly revised proposal, each Allergan share would be exchanged for $72.00 in cash and 0.83 shares of Valeant common stock, plus a Contingent Value Right for DARPin of up to $25.00 per share in value. This is up from the $58.30 in cash, plus shares and the CVR, that Valeant offered just two days ago. MAJOR MOVERS: Among the notable gainers was Retrophin (RTRX), which gained $1.74, or 13.51%, to $14.62 after announcing a license agreement with Mission Pharmacal for Thiola and revising its guidance. Also higher was NPS Pharmaceuticals (NPSP), which jumped $3.68, or 13.41%, to $31.13 after FT Alphaville, citing "usually well informed sources," said Shire (SHPG) has held internal discussions about a potential cash takeover offer for its smaller pharmaceutical industry peer. Among the noteworthy losers was Infoblox (BLOX), which plunged $7.56, or 36.84%, to $12.96 after the company's outlook for the new quarter missed expectations, its CEO Robert Thomas said he will step down and the shares were downgraded by at least six Street research firms. Other decliners following their earnings reports were data analysis software provider Splunk (SPLK), which fell $8.18, or 16.35%, to $41.86, and "Hunger Games" producer Lions Gate (LGF), which dropped $3.40, or 11.51%, to $26.13. INDEXES: The Dow was up 18.43, or 0.11%, to 16,717.17, the Nasdaq was down 5.33, or 0.13%, to 4,242.62, and the S&P 500 was up 3.54, or 0.18%, to 1,923.57.
News For AGN;VRX;BLOX;LGF;NPSP;SHPG;RTRX;SPLK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 27, 2015
07:40 EDTBLOXInfoblox should be bought on any weakness, says Cowen
Subscribe for More Information
May 26, 2015
20:46 EDTLGFCowen to hold a conference
Subscribe for More Information
08:14 EDTSHPGBoston Biotech Conferences to hold a conference
Subscribe for More Information
07:32 EDTBLOXInfoblox target raised ahead of Thursday's results at Deutsche Bank
Subscribe for More Information
May 22, 2015
10:03 EDTLGFHigh option volume stocks
High option volume stocks: HBB RENN ONTY LGF JMEI DK JO INTU TFM
09:26 EDTRTRXRetrophin management to meet with Leerink
Subscribe for More Information
May 21, 2015
19:54 EDTVRXValeant to expand Canadian presence in coming years, Globe and Mail says
Subscribe for More Information
16:02 EDTLGFLionsgate reports Q4 adjusted EPS 41c, consensus 32c
Subscribe for More Information
15:01 EDTLGFNotable companies reporting after market close
Subscribe for More Information
07:37 EDTSHPGPfizer replaces AbbVie as top global pharma pick at Jefferies
Subscribe for More Information
07:04 EDTSPLKSplunk volatility elevated into Q1 and outlook
Subscribe for More Information
May 20, 2015
10:00 EDTLGFOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:00 EDTSPLKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:16 EDTSPLKSplunk Q1 revenue likely to beat expectations, says Oppenheimer
Subscribe for More Information
07:09 EDTSPLKSplunk upgraded to Outperform from Neutral at Macquarie
Macquarie upgraded Splunk to Outperform with a $87 price target based on efforts to expand new customer adoption and the application layer. The firm said Splunk has provided increased flexibility in the product evaluation phase, which should improve new customer adoption, and extended efforts to build full solutions in the application layer. Macquarie also believes Splunk could emerge as a winner in Big Data analytics, resulting in new customer wins.
06:37 EDTVRXSources: Valeant in talks to buy Amoun Pharmaceutical, Bloomberg reports
Subscribe for More Information
06:32 EDTVRXValeant CEO sees quintupling in Asia sales by 2020, Reuters reports
Subscribe for More Information
05:44 EDTLGFLionsgate initiated with a Buy at Jefferies
Subscribe for More Information
May 18, 2015
12:00 EDTSPLKSplunk selloff following CTO change unwarranted, says Cantor
Subscribe for More Information
08:07 EDTSPLKSplunk appoints Snehal Antani as Chief Technology Officer
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use